ArticlePloS one2022

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Florian Heitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.